PHARMA
Nolato Medical Expands Beijing Production Facility
Swedish polymer manufacturer Nolato is expanding its production facility in Beijing with an additional 2,200 square meters of clean room facility.
Shanghai BravoBio Obtains China Rights For RotaShield®
The International Medica Foundation has sub-licensed the first rotavirus vaccine clinically tested for use in newborns to Shanghai BravoBio.
Simcere Pharma To Sell Equity Stake In Bodapharmaceutical
Simcere Pharma has sold its stake in Jilin Bodapharmaceutical Co., Ltd. to Zhuhai Rongding Equity Investment Partnership L.P.
EntreMed Files New Clinical Trial With CFDA For ENMD-2076
EntreMed, Inc. has submitted a new clinical trial application with the CFDA for its proprietary oncology drug candidate, ENMD-2076.
Linagliptin Controlled Type II Diabetes In Asian Clinical Trials
Two phase III clinical studies show that linagliptin improved blood glucose control in Asian adults with type II diabetes.
Pfizer, GSK, Siemens & A*STAR Form R&D Consortium
Pfizer, Glaxo Wellcome, and Siemens have signed on to a new program that aims to help companies increase productivity in the pharmaceutical and chemical sectors.
BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China
BioLineRx has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharma to commercialize BL-8030 in China.
BMS, Simcere Pharma To Co-Develop Orencia® SC In China
BMS and Simcere will co-develop and co-commercialize the subcutaneous formulation of Orencia® for the treatment of rheumatoid arthritis in China.
Fujifilm & Dr. Reddy’s Call Off Generic Drugs Joint Venture In Japan
FUJIFILM and Dr. Reddy's Laboratories have terminated an MOU to enter into a joint venture for the Japanese generics drugs market.
